Emerging Leaders in Cancer Chemotherapy and Pharmacology

Articles (4 in this collection)

1. Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1

   Authors (first, second and last of 22)

   • Kiyoaki Uryu
   • Yoshinori Imamura
   • Hironobu Minami

   • Content type: Original Article
   • Published: 08 April 2024

   

2. Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities

   Authors

   • Sean G. Rudd

   • Content type: Review Article
   • Open Access
   • Published: 15 July 2023

   • Pages: 241 - 251

   

3. Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients

   Authors (first, second and last of 12)

   • Stefanie L. Groenland
   • J. M. Janssen
   • N. Steeghs

   • Content type: Original Article
   • Published: 22 March 2023

   • Pages: 447 - 456

   

4. Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

   Authors (first, second and last of 16)

   • Nikki de Rouw
   • René J. Boosman
   • Rob ter Heine

   • Content type: Original Article
   • Published: 21 November 2022

   • Pages: 33 - 42